The Genomics Revolution in the Greater South East
Sector insightsA snapshot of the genomics landscape across Cambridge, London, Oxford and the Greater South East, highlighting investment, industry growth and leading research programmes.
Overview
Genomics is emerging as one of the most dynamic areas of life sciences across Cambridge, London, Oxford and the Greater South East. This infographic outlines the scale of the region’s industry, which in 2018 was valued at nearly £1 billion and growing at an expected annual rate of 20%—far above the global average. It highlights more than £370 million of investment into genomics companies between 2013 and 2017, along with major national research programmes such as the 100,000 Genomes Project and East London Genes & Health.
It also showcases the companies shaping the region’s leadership in sequencing, diagnostics and clinical genomics, and the infrastructure supporting growth, including six Genomic Medicine Centres.
Key takeaways
- The UK’s genomics industry is scaling rapidlyThe industry was valued at nearly £1 billion with an expected growth rate of 20%—significantly higher than the global rate of 12–15%. Over 10,000 people were employed in genomics, with 40% of UK companies based in Cambridge, London and Oxford.
- Significant investment and commercial momentumMore than £370 million was invested into genomics companies in the GSE between 2013 and 2017, representing 87% of total UK genomics investment. Sequencing-focused companies generated revenues exceeding £500 million in 2016.
- World-leading research initiativesMajor programmes—including the 100,000 Genomes Project and East London Genes & Health—are advancing understanding of rare diseases, cancer and population health, while strengthening clinical innovation across the region.
